CCR2 and musculoskeletal system disorder: For these experiments, WT and CCR2-DTR mice were administered DT at day -1 and day +2 relative to virus inoculation and mice were monitored for 10 days, the peak of the acute disease phase [54, 58, 64], for effects on weight gain and for the development of virus-induced musculoskeletal disease signs.